Today's Top Alzheimer's News
Join our Alzheimer's Talks TODAY to learn about veterans and Alzheimer’s disease, and current findings and forecast from the U.S. Department of Veterans Affairs. With Veterans Day approaching, two experts from the Department of Veterans Affairs join us: Dr. Tom Edes, who oversees Geriatrics and Extended Care Services for VA Clinical Operations, and Dr. Alex Chiu, who leads VA’s portfolio of Alzheimer’s disease research. Today at 4:00pm (EST).
Join WomenAgainstAlzheimer’s 30-Day Brain Health Challenge, and take the first important step toward making your brain health “top of mind.” Prioritize your brain health with an easy-to-incorporate challenge delivered daily to your inbox for 30 days.
(ICYMI) An October 25, 2018 Reno News 4/FOX 11 article started by quoting UsAgainstAlzheimer’s Founding Board Member Meryl Comer, “We are really a composite of our life experiences -- memory layered upon memory and Alzheimer's steals that away.” The article chronicles different Nevadans with Alzheimer’s or other dementias.
RESEARCH AND SCIENCE
A November 7, 2018 NPR article looked at the potential use of THC (tetrahydrocannabinol), the active ingredient in marijuana, to treat or prevent Alzheimer’s disease. Results from a study on mice at University Medical Center Goettingen, Germany were presented this week at the Society for Neuroscience meeting in San Diego. Regarding future studies in humans, ““There are just no venues to do it,” said Jamie Roitman, an associate professor of psychology at the University of Illinois at Chicago, who presented a study about cannabis use in adolescent rats. Getting approval for any study involving people and compounds related to marijuana is “very difficult,” she said, despite the fact that the drug is now legal in many states.”
According to a November 5, 2018 Birmingham Business Journal article, the University of Alabama at Birmingham in collaboration with the University of Chicago and Emory University, received a $5.5 million, five-year grant from the National Institute on Aging. “These are people who develop the pathology of Alzheimer’s disease: the tangles of tau protein and the accumulation of amyloid protein in the brain. But they don’t develop the symptoms of the disease and are resilient to its effects. If we can understand why this segment of the population is resilient, we might have a new target for slowing or preventing the disease in those who are not resilient,” said UAB Department of Neurology Assistant Professor Jeremy Herskowitz.
A November 6, 2018 Alzheimer’s Speaks Radio segment featured the Live 2 B Healthy team, helping create better senior housing experiences by encouraging seniors of all abilities to improve their strength and balance in a fun group setting. Host Lori La Bey speaks with Cory Czepa, Bryan Schreifels and Kelly Nygard.
CLINICAL TRIAL SPOTLIGHT
A November 5, 2018 Fox 5 Atlanta broadcast segment spotlighted Pete Mitchell, who is part of the Generation Program Alzheimer's prevention study. The study runs five to eight years involving participants between 60 and 75, with no history of memory problems, but who carry the APOE4 gene, a major hallmark of AD.